$0.87
0.09[11.54%]
At close: May 30
$0.87
0[0.00%]
After Hours: 5:28PM EDT
Purple Biotech
(NASDAQ:PPBT)Purple Biotech Stock (NASDAQ:PPBT), Analyst Ratings, Price Targets, Predictions
Purple Biotech Ltd has a consensus price target of $10, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Chardan Capital on May 21, 2024, April 26, 2024, and March 7, 2024. With an average price target of $10.33 between HC Wainwright & Co., HC Wainwright & Co., and Chardan Capital, there's an implied 1087.74% upside for Purple Biotech Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Chardan Capital
JonesTrading
Chardan Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Purple Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/21/2024 | Buy Now | 1049.43% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2024 | Buy Now | 1049.43% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 1164.37% | Chardan Capital | Daniil Gataulin | $11 → $11 | Maintains | Buy | Get Alert |
| 03/05/2024 | Buy Now | 1049.43% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | 1049.43% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2023 | Buy Now | 1049.43% | HC Wainwright & Co. | Emily Bodnar | $9 → $10 | Maintains | Buy | Get Alert |
| 08/31/2023 | Buy Now | 934.48% | HC Wainwright & Co. | Emily Bodnar | $7 → $9 | Maintains | Buy | Get Alert |
| 08/30/2023 | Buy Now | 934.48% | HC Wainwright & Co. | Emily Bodnar | $7 → $9 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | 819.54% | JonesTrading | Catherine Novack | → $8 | Initiates | → Buy | Get Alert |
| 05/17/2023 | Buy Now | 704.6% | HC Wainwright & Co. | Emily Bodnar | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2023 | Buy Now | 1164.37% | Chardan Capital | Matthew Barcus | → $11 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2023 | Buy Now | 704.6% | HC Wainwright & Co. | Emily Bodnar | → $7 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | Buy Now | 1164.37% | Chardan Capital | Matthew Barcus | → $11 | Reiterates | → Buy | Get Alert |
| 10/17/2022 | Buy Now | 704.6% | HC Wainwright & Co. | Emily Bodnar | → $7 | Initiates | → Buy | Get Alert |
| 09/08/2022 | Buy Now | 1164.37% | Chardan Capital | Matthew Barcus | → $11 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Purple Biotech (PPBT)?
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by HC Wainwright & Co. on May 21, 2024. The analyst firm set a price target for $10.00 expecting PPBT to rise to within 12 months (a possible 1049.43% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Purple Biotech (PPBT)?
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by HC Wainwright & Co., and Purple Biotech reiterated their buy rating.
When was the last upgrade for Purple Biotech (PPBT)?
There is no last upgrade for Purple Biotech.
When was the last downgrade for Purple Biotech (PPBT)?
There is no last downgrade for Purple Biotech.
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on May 21, 2024 so you should expect the next rating to be made available sometime around May 21, 2025.
Is the Analyst Rating Purple Biotech (PPBT) correct?
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a reiterated with a price target of $10.00 to $10.00. The current price Purple Biotech (PPBT) is trading at is $0.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.